Emergent BioSolutions

EBSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$346.608 M

$6.76 +3.21%

Close of 22 Sept 2026

Revenue

$742.9M

#1699 by revenue

Earnings

$52.6M

#1545 by earnings

Shares outstanding

51,273,336

Latest filing cover page

P/E ratio

6.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#228Enanta PharmaceuticalsENTA$361.7M
#229EvommuneEVMN$348.4M
#230Emergent BioSolutionsEBS$346.6M
#231Perspective TherapeuticsCATX$337.9M
#232Abeona TherapeuticsABEO$332.8M

What if Emergent BioSolutions were worth as much as…

Open the what-if tool →

Gold $30.2T

$589,662.62

Per share 87,228× higher

Bitcoin $1.74T

$33,968.05

Per share 5,025× higher

Nvidia $5.52T

$107,575.74

Per share 15,914× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Emergent BioSolutions are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.